| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 2 | +12.2 K | 100% | $2.15 | +$26.2 K |
| Sells | 0 | ||||
| Net | +2 | +12.2 K | 100% | +$26.2 K |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Versant Venture Capital VI, L.P. | 10%+ Owner | $14.9 M | Apr 29, 2022 | ||
| Versant Vantage II, L.P. | 10%+ Owner | $10.1 M | Apr 29, 2022 | ||
| Rock Springs Capital Management LP | 10%+ Owner | $352 K | Dec 30, 2021 | ||
| Justin Trojanowski | Corporate Controller | $47.9 K | +$16.2 K | +51.1% | Jun 28, 2024 |
| Samuel Whiting | Chief Medical Officer | $20.4 K | +$9.95 K | +95.3% | Jul 2, 2024 |
| Stephen R. Brady | President and CEO, Director | Jan 3, 2024 | |||
| Stella Xu | Director | Jul 1, 2021 | |||
| Nicholas Maestas | VP of Strategy and Finance | Jan 3, 2024 | |||
| Pierre Lorenzo | Corporate Controller | Jun 21, 2022 | |||
| Thomas W. Dubensky | President, Director | Jan 3, 2023 | |||
| Christine Pellizzari | Director | Jun 13, 2024 | |||
| Michael Raab | Director | Jun 13, 2024 | |||
| Geoffrey Nichol | Director | Jun 13, 2024 | |||
| Ronit Simantov | Director | Jun 13, 2024 | |||
| Thomas Woiwode | Director | Jun 17, 2022 |
| Insider | Class | Transaction | % | Value $ | Price $ | Shares | Shares Owned | Date | Ownership |
|---|